←back to Blog

Deep learning reconstruction combined with contrast enhancement boost improves image quality of low-contrast-dose ctpa: a prospective randomized study

BMC Med Imaging. 2026 Oct 30;26(1):628. doi: 10.1186/s12880-026-02998-6.

ABSTRACT

BACKGROUND: High-quality CT pulmonary angiography (CTPA) is vital for pulmonary embolism diagnosis. This study evaluated the effect of combining deep learning reconstruction (DLR) with contrast enhancement boost (CE-boost) in low-contrast-dose CTPA.

METHODS: In this prospective randomized trial (September-December 2023), 106 patients were assigned to a low-contrast-dose (3 mL/s, 30 mL; Group A) or standard-contrast-dose (4 mL/s, 50 mL; Group B) CTPA protocol. Four image datasets were generated from each case in Group A using a 2 × 2 factorial design: A1, hybrid iterative reconstruction (HIR); A2, DLR (AiCE); A3, HIR plus CE-boost; A4, DLR plus CE-boost. Group B used HIR. Quantitative (CT attenuation, noise, SNR, CNR) and qualitative (overall image quality, subsegmental artery visibility) endpoints were assessed with linear mixed models and ART ANOVA with Holm correction.

RESULTS: Each group comprised 53 patients (mean age: 59 ± 15 vs. 58 ± 18 years; 27 vs. 26 women). DLR significantly reduced noise and improved SNR/CNR (all Holm-corrected p < 0.001). CE-boost significantly increased CT attenuation, SNR, and CNR (all p < 0.001) without affecting noise. A significant DLR × CE-boost interaction was observed for CNR in all ROIs (all p < 0.05), indicating synergy. Qualitatively, DLR improved both overall quality and visibility, whereas CE-boost improved visibility only. The combined protocol (A4) achieved the highest CNR and visibility among all four datasets, significantly surpassing both the baseline low-contrast-dose (A1) and standard-contrast-dose (Group B) protocols (all Bonferroni-corrected p < 0.0083/0.025).

CONCLUSIONS: Combining DLR with CE-boost synergistically optimizes low-contrast-dose CTPA, enabling a 40% reduction in iodine load and a 25% reduction in injection rate while enhancing image quality beyond that of standard-contrast-dose imaging. This protocol may offer a viable strategy for patients requiring strict contrast limitation.

PMID:43046152 | DOI:10.1186/s12880-026-02998-6